Directory
>
David Lichter
David Lichter
Founder & Owner | Seres Therapeutics
United States
David Lichter
Summary
David Lichter is an accomplished executive in clinical research and program leadership, with a strong focus on oncology and inflammatory diseases. He has a rich background in biotechnology and molecular biology, having transitioned from a research scientist to an executive director at Seres Therapeutics. David is not only an inventor and entrepreneur, but he also champions community engagement and STEM education. His leadership has been recognized through multiple awards, highlighting his contributions to corporate social responsibility. With a unique blend of scientific expertise and business acumen, he leads innovative clinical programs aimed at improving patient outcomes. David's passion for science is matched by his commitment to mentoring the next generation of scientists. He is also the founder of Lock Horns LLC, showcasing his entrepreneurial spirit.
David Lichter
Work Experience
Founder & Owner at
Lock Horns
January 2024 - Present
Executive Director, Clinical Research / Clinical Science & Program Lead for SER-155 at
Seres Therapeutics
February 2022 - Present
Fitness Professional at
Self-Employed
October 2003 - Present
Senior Director, Clinical Research / Clinical Science & Program Lead for SER-287 & SER-301 at
Seres Therapeutics
February 2020 - February 2022
Director, Clinical Research / Clinical Science at
Seres Therapeutics
October 2017 - February 2020
Sr. Clinical Research Lead at
Leica Biosystems
August 2017 - October 2017
Clinical Research Lead - Clinical Affairs, Pharma Partnerships at
Leica Biosystems
January 2014 - August 2017
Research Investigator - Translational Medicine at
Takeda Oncology
March 2010 - January 2014
Senior Research Associate - Molecular/Translational Medicine at
Millennium Pharmaceuticals
June 2007 - February 2010
Research Associate - Molecular Medicine / Oncology Clinical Development at
Millennium Pharmaceuticals
May 2004 - May 2007
Research Assistant - Molecular Medicine at
Millennium Pharmaceuticals
October 2003 - April 2004
Histology Research at
Regeneron
June 2002 - August 2002
David Lichter
Education
Harvard University, Alm
University of Rochester, Bachelor Of Science
Frequently Asked Questions about David Lichter
What is David Lichter email address?
David Lichter's primary email address is ********@serestherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does David Lichter work for?
David Lichter is a Founder & Owner at Seres Therapeutics, a company specializing in Commercial physical research.
Where David Lichter graduated from?
David Lichter holds a degree in Biotechnology from Harvard University.
How can I directly contact David Lichter?
To contact David Lichter directly, you can use the email address ********@serestherapeutics.com. Complete contact information is available upon registration with Muraena.
Who is David Lichter?
David Lichter is an accomplished executive in clinical research and program leadership, with a strong focus on oncology and inflammatory diseases. He has a rich background in biotechnology and molecular biology, having transitioned from a research scientist to an executive director at Seres Therapeutics. David is not only an inventor and entrepreneur, but he also champions community engagement and STEM education. His leadership has been recognized through multiple awards, highlighting his contributions to corporate social responsibility. With a unique blend of scientific expertise and business acumen, he leads innovative clinical programs aimed at improving patient outcomes. David's passion for science is matched by his commitment to mentoring the next generation of scientists. He is also the founder of Lock Horns LLC, showcasing his entrepreneurial spirit.
David`s contact details
********@serestherapeutics.com
Colleagues
Chief Medical Officer
President, Chief Executive Officer
VP Medical Affairs
Senior Vice President & Chief Information Officer
Senior Vice President, R&D
Executive Director, Clinical Operations